Labcorp names Brian Caveney biopharma lab services president, chief medical and scientific officer
Reuters2026/08/14 12:56- Megan D. Bailey will step down as executive vice president and president, Central Laboratories and International, effective Sept. 4, 2026.
- Brian J. Caveney, M.D., will take the executive vice president and president, Biopharma Laboratory Services role on Sept. 1, 2026.
- Caveney currently leads Early Development Research Laboratories as executive vice president and president, serving as chief medical and scientific officer.
- Expanded remit includes oversight of Early Development Research Laboratories, Central Laboratories.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Delta Electronics (Thailand)'s Recent Selloff Presents Accumulation Opportunity -- Market Talk
The data center construction boom may increase inflationary pressure, and the Reserve Bank of Australia may be forced to maintain high interest rates.
The data center construction boom in Australia may lead to demand exceeding the supply capacity of the economy, which could push up inflation and force the Reserve Bank of Australia to maintain higher interest rates.
Reliance step-down unit Roptonal dissolves in Cyprus with effect Aug. 18, 2026
Crypto prices
More
